Cell Adhesion Marker Antibodies are indicated in the understanding of cellular adhesion, the binding mechanism of a cell surface to another structure, implicated in the process of maintaining multicellular structures.
Cell adhesions marker antibodies are useful for research in understanding aberrations in the ability of cell structures to adhere to each other.
Cell adhesion antibodies are implicated in cancer metastatsis, and have also been suggested for several other relevant disease processes, including atherosclerosis, acute coronary syndromes, reperfusion injury and allograft vasculopathy.
Cell Adhesion Marker Antibodies area available in the following volumes including 0.05 ml, 0.1 ml, 0.2 ml, 1 ml and 2 ml.
|
|
EPCAM; CD326 Antibody- Rat Anti-EPCAM
Epithelial Cell Adhesion Molecule (EpCAM) is a 40 kDa cell surface antigen. This antigen has been identified independently by a number of groups, and has been known by a variety of names. Several monoclonal antibodies have been raised against EpCAM, many of which have been described as tumour specific molecules on carcinomas. EpCAM is a Type 1 transmembrane glycoprotein. It is expressed on the basolateral membrane of cells by the majority of epithelial tissues, with the exception of adult squamous epithelium and some specific epithelial cell types including hepatocytes and gastric epithelial cells. EpCAM expression has been reported to be a possible marker of early malignancy, with expression being increased in tumour cells, and de novo expression being seen in dysplastic squamous epithelium
£226.00
Fibronectin Antibody - Mouse Anti-Human Fibronectin
Fibronectins bind cell surfaces and various compounds including collagen, fibrin, heparin, DNA, and actin. Fibronectins are involved in cell adhesion, cell motility, opsonization, wound healing, and maintenance of cell shape.Anastellin binds fibronectin and induces fibril formation. This fibronectin polymer, named superfibronectin, exhibits enhanced adhesive properties. Both anastellin and superfibronectin inhibit tumor growth, angiogenesis and metastasis. Anastellin activates p38 MAPK and inhibits lysophospholipid signaling
£226.00
